Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient

Dermatologic Surgery

Volumn 38, Issue 11, 2012, Pages 1863-1866

  Wolfe, Christopher M ^a   Green, W Harris ^b   Cognetta, Armand B ^b   Hatfield, H Keith ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Dermatology Associates of Tallahassee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROACETIC ACID; VISMODEGIB;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER GROWTH; CANCER STAGING; CASE REPORT; CHEMOSURGERY; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DEHYDRATION; DIARRHEA; DISEASE DURATION; FEMALE; GENETIC DISORDER; HAIR LOSS; HISTOLOGY; HUMAN; MUSCLE SPASM; NAUSEA; PRIORITY JOURNAL; REBOUND; REHYDRATION; TASTE AVERSION; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 84868154664     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2012.02513.x     Document Type: Article

References (10)

1. Lo Muzio L,. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008; 3: 32.
2. Gorlin RJ,. Nevoid basal cell carcinoma syndrome. Dermatol Clin 1995; 13: 113-25.
3. Evans DG, Ladusans EJ, Rimmer S, Burnell LD, et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 1993; 30: 460-4.
4. Ingham PW, McMahon AP,. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059-87.
5. Rubin LL, de Sauvage FJ,. Targeting the hedgehog pathway in cancer. Nat Rev Drug Discov 2006; 5: 1026-33.
6. Medicine USNLo. PTCH1. Genetics Home Reference 2008 [on-line]. Available from: http://ghr.nlm.nih.gov/gene/PTCH1. Accessed February 6, 2012.
7. Rubin AI, Chen EH, Ratner D,. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-9.
8. Xie J, Murone M, Luoh SM, Ryan A, et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391: 90-2.
9. FDA. Erivedge (vismodegib) Prescribing Information January 2012 [on-line]. Available from: http://www.accessdata.fda.gov/drugsatfda-docs/label/ 2008/021415s003lbl.pdf. Accessed February 6, 2012.
10. Kovach BT, Sams HH, Stasko T,. Systemic strategies for chemoprevention of skin cancers in transplant recipients. Clin Transplant 2005; 19: 726-34.